Casodex 150mg Tablet

Casodex 150mg Tablet

S4
PDF Leaflet Revision Date: 17 February 2017

API: Bicalutamide | Company: Astrazeneca

Clinical Summary

Quick overview from the medicine insert

Indication

Management of locally advanced prostate cancer.

Dosage (summary)

150 mg once daily for 2 years or until progression.

Special Populations

  • Moderate to severe hepatic impairment

Pregnancy & Breastfeeding

Contraindicated in females, pregnant or nursing women.

Key Drug Interactions

  • CYP 3A4 inhibitors
  • Coumarin anticoagulants

Contraindications

  • Females
  • Children
  • Hypersensitivity to bicalutamide

Common side effects

  • Rash
  • Gynaecomastia
  • Asthenia
  • Decreased libido
  • Somnolence

Counselling Points

  • Monitor liver function
  • Avoid driving if somnolence occurs
  • Inform about potential gynaecomastia

Serious warnings

  • Severe hepatic changes
  • Anti-androgen withdrawal syndrome
Important Disclaimer

The Casodex 150mg Tablet professional information leaflet below is the property of Astrazeneca and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

Healthcare Professionals Only

This content is for registered healthcare professionals

Sign in or create a free account to read the full package insert.

Free for HPCSA-registered professionals. Powered by Medinsert.

Successfully Stashed! 💊

This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

View My Favourites